Reversan - CAS 313397-13-6

Reversan (CBLC4H10), a small molecule inhibitor that acts on multidrug resistance-associated protein 1 (MRP1) and P-glycoprotein (Pgp), has been found to improve the efficacy of chemotherapy for glioblastoma, with the advantages of being highly effective and non-toxic.

P-gp, MRP, Neurokinin receptor

Immunology/Inflammation, GPCR/G Protein, Neuroscience, Membrane transporter/Ion channel

313378

0.9905

C26H27N5O2

441.53

O=C(NCCCN1CCOCC1)C=2C=NN3C2N=C(C=C3C=4C=CC=CC4)C=5C=CC=CC5

-20°C

Ice Packs

Small Compound